Showing results (21-30 of 477) with videos related to
Sort By:
Pageof 48
Blood|July 15, 1995
Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodiesM Galli, G Finazzi, E M Bevers, et al.American Journal of Hematology|November 1, 1992
Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndromeG Finazzi, P Bellavita, A Falanga, et al.Leukemia & Lymphoma|September 1, 1996
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centersT Barbui, G Finazzi, E Dupuy, et al.Italian Journal of Neurological Sciences|October 1, 1994
Essential thrombocytemia and ischemic stroke: report of six casesL Casto, M Camerlingo, G Finazzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemiaS Cortelazzo, P Viero, G Finazzi, et al.British Journal of Haematology|December 19, 1998
No treatment for low-risk thrombocythaemia: results from a prospective studyM Ruggeri, G Finazzi, A Tosetto, et al.Blood|January 1, 1991
High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpuraS Cortelazzo, G Finazzi, M Buelli, et al.Neurology|September 1, 1991
Inherited protein C deficiency and nonhemorrhagic arterial stroke in young adultsM Camerlingo, G Finazzi, L Casto, et al.Thrombosis and Haemostasis|June 12, 1999
The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profileM Galli, G Finazzi, F Norbis, et al.Thrombosis and Haemostasis|December 1, 1994
Recombinant versus high-sensitivity conventional thromboplastin: a randomized clinical study in patients on oral anticoagulationG Finazzi, A Falanga, M Galli, et al.Pageof 48